MedPath

PEP-1324: Glycemic Response Testing

Not Applicable
Conditions
Glycemic Response
Interventions
Other: Nutrient formulation
Registration Number
NCT02037854
Lead Sponsor
PepsiCo Global R&D
Brief Summary

The purpose of this study is to assess whether food ingredient(s) affect glycemic and insulinemic responses.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
12
Inclusion Criteria
  • Subject is 18-75 years of age
  • Subject is male or non-pregnant females, 18-75 years of age, inclusive
  • Subject has a body mass index (BMI) ≥ 20.0 and < 35 kg/m² at screening (visit 1).
  • Subject has to be non-smoker.
  • Subject is willing to maintain habitual diet, physical activity pattern, and body weight throughout the trial.
  • Subject is willing to maintain current dietary supplement use throughout the trial. On test days, subject agrees not to take any dietary supplements until dismissal from the GI labs. Failure to comply will result in a rescheduled test visit.
  • Subject has normal fasting serum glucose (<7.0mmol/L capillary corresponding to whole blood glucose <6.3mmol/L).
  • Subject is willing to abstain from alcohol consumption and avoid vigorous physical activity for 24 h prior to all test visits.
  • Subject has no health conditions that would prevent him from fulfilling the study requirements as judged by the Investigator on the basis of medical history.
  • Subject understands the study procedures and signs forms providing informed consent to participate in the study and authorization for release of relevant protected health information to the study investigator.
Exclusion Criteria

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Nutrient formulationNutrient formulationNutrient formulations with variable amounts of active ingredients.
PlaceboNutrient formulationA nutrient formulation without the active ingredient
Primary Outcome Measures
NameTimeMethod
Incremental area under the blood glucose response cruve0-2 hours
Secondary Outcome Measures
NameTimeMethod
peak insulin0-2 hours
peak blood glucose0-2 hours

Trial Locations

Locations (1)

GI Labs

🇨🇦

Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath